An AI-designed drug is currently in trials, prompting a focus on global legal and ethical standards.
Steady: 1 development in the last 24 hours, 1 in the last 7 days
Updated yesterday
The latest in this situation
How it started
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
An AI-designed drug is currently in trials, prompting a focus on global legal and ethical standards.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- AI labs are improving personalized medicine treatments, prompting FDA requirements for human proof points in drug approval.Sub-event
AI-designed drug trials are underway, prompting focus on global legal and ethical standards.1 source
Keep exploring
The entities involved
-
Isomorphic Labs
British multinational artificial intelligence company
Nothing else this week.
- FDA
-
United Nations
global international and intergovernmental organization
Related events
- FDA approval is the goal for product candidates from Daré Bioscience, Inc.
- Aidoc received FDA clearance for its medical AI solutions, which are developed by the company and co-founded by Elad Walach.
- FDA approved a medical device from Abbott and supported a PARADIGM study based on data from the Cleveland Clinic.
- FDA, LabCorp, and Charles River Laboratories formed a collaboration to evaluate the potential for medicine abuse.